Pharma & Biotech Stock Outlook – April 2012 – Industry Outlook | RenewableEnergyWorld.com

Pharma & Biotech Stock Outlook – April 2012 – Industry Outlook

By: Stock Market News & Stocks to Watch from StraightStocks

Posted on April 26, 2012 at 16:05 PM EDT

The effects of the genericization will be felt mostly in 2012, which will be a challenging year for several companies.

Related Stocks:

Abbott Laboratories Bristol-Myers Squibb Co. Celgene Corp Dentsply International, Inc. Eli Lilly & Co. GlaxoSmithKline PLC ADS Johnson & Johnson Merck & Co., Inc. Pfizer, Inc. Vertex Pharmaceuticals, Inc.

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates